Canopy Growth Corp (CGC) - Total Assets
Based on the latest financial reports, Canopy Growth Corp (CGC) holds total assets worth $1.10 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Canopy Growth Corp - Total Assets Trend (2010–2026)
This chart illustrates how Canopy Growth Corp's total assets have evolved over time, based on quarterly financial data. Also see CGC stock market capitalisation for the company's overall valuation and market capitalisation.
Canopy Growth Corp - Asset Composition Analysis
Current Asset Composition (March 2026)
Canopy Growth Corp's total assets of $1.10 Billion consist of 47.3% current assets and 52.7% non-current assets. Review CGC current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 32.6% |
| Accounts Receivable | $36.29 Million | 3.2% |
| Inventory | $154.12 Million | 13.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $128.87 Million | 11.5% |
| Goodwill | $77.66 Million | 6.9% |
Asset Composition Trend (2010–2026)
This chart illustrates how Canopy Growth Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See CGC stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Canopy Growth Corp's current assets represent 47.3% of total assets in 2026, a decrease from 100.0% in 2010.
- Cash Position: Cash and equivalents constituted 32.6% of total assets in 2026, up from 6.5% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 13.8% of total assets.
Canopy Growth Corp Competitors by Total Assets
Key competitors of Canopy Growth Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Kamada
TA:KMDA
|
Israel | ILA377.21 Million |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Viatris Inc
NASDAQ:VTRS
|
USA | $35.04 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
|
China | CN¥4.49 Billion |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
USA | $199.45 Million |
Canopy Growth Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.04 | 3.07 | 9.63 |
| Quick Ratio | 2.39 | 2.12 | 8.27 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $339.61 Million | $204.69 Million | $1.77 Billion |
Canopy Growth Corp - Advanced Valuation Insights
This section examines the relationship between Canopy Growth Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.84 |
| Latest Market Cap to Assets Ratio | 0.36 |
| Asset Growth Rate (YoY) | 21.9% |
| Total Assets | $1.12 Billion |
| Market Capitalization | $397.27 Million USD |
Valuation Analysis
Below Book Valuation: The market values Canopy Growth Corp's assets below their book value (0.36x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Canopy Growth Corp's assets grew by 21.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Canopy Growth Corp (2010–2026)
The table below shows the annual total assets of Canopy Growth Corp from 2010 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | $1.12 Billion | +21.91% |
| 2025-03-31 | $917.70 Million | -29.43% |
| 2024-03-31 | $1.30 Billion | -46.70% |
| 2023-03-31 | $2.44 Billion | -56.47% |
| 2022-03-31 | $5.61 Billion | -17.85% |
| 2021-03-31 | $6.82 Billion | +41.62% |
| 2020-03-31 | $4.82 Billion | -44.82% |
| 2019-03-31 | $8.73 Billion | +507.72% |
| 2018-03-31 | $1.44 Billion | +112.04% |
| 2017-03-31 | $677.61 Million | +372.66% |
| 2016-03-31 | $143.36 Million | +200.08% |
| 2015-03-31 | $47.77 Million | +84.01% |
| 2014-12-31 | $25.96 Million | +403.78% |
| 2014-03-31 | $5.15 Million | +914.83% |
| 2013-03-31 | $507.81K | -6.68% |
| 2012-03-31 | $544.13K | -3.39% |
| 2011-03-31 | $563.21K | -4.26% |
| 2010-03-31 | $588.30K | -- |
About Canopy Growth Corp
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and … Read more